Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2950 of 3270 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 01/31/17
Due: 01/31/18
Phase: N/A
Priority: Normal
Start: 03/01/21
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 02/07/23
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 06/14/23
End: 12/14/23
Due: 12/14/24
Phase: N/A
Priority: Normal
Start: 10/15/19
End: 10/15/24
Due: 10/15/25
Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells
Phase: N/A
Priority: Normal
Start: 05/06/14
End: 06/16/22
Due: 06/16/23
Phase: N/A
Priority: Normal
Start: 03/09/24
End: 09/09/25
Due: 09/09/26
Phase: N/A
Priority: Normal
Start: 09/21/19
End: 09/21/25
Due: 09/21/26
Phase: N/A
Priority: Normal
Start: 06/01/20
End: 03/01/21
Due: 03/01/22
Phase: N/A
Priority: Normal
Start: 06/30/24
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 10/31/10
End: 05/31/15
Due: 05/31/16
Phase: N/A
Priority: Normal
Start: 02/20/23
End: 02/20/26
Due: 02/20/27
Phase: N/A
Priority: Normal
Start: 10/12/17
End: 09/30/21
Due: 09/30/22
Phase: N/A
Priority: Normal
Start: 01/31/06
End: 06/30/10
Due: 06/30/11
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 02/28/13
Due: 02/28/14
Phase: N/A
Priority: Normal
Start: 04/24/20
End: 10/24/22
Due: 10/24/23
Phase: N/A
Priority: Normal
Start: 05/31/01
End: 07/31/05
Due: 07/31/06
Phase: N/A
Priority: Normal
Start: 09/22/20
End: 03/23/24
Due: 03/23/25
Phase: N/A
Priority: Normal
Start: 07/02/20
End: 07/31/32
Due: 07/31/33
Phase: N/A
Priority: Normal
Start: 11/30/24
End: 04/30/29
Due: 04/30/30
Phase: N/A
Priority: Normal
Start: 12/18/23
End: 10/31/28
Due: 10/31/29
Phase: N/A
Priority: Normal
Start: 03/31/25
End: 09/30/25
Due: 09/30/26
Phase: N/A
Priority: Normal
Start: 11/27/20
End: 12/02/20
Due: 12/02/21
Phase: N/A
Priority: Normal
Start: 03/05/25
End: 03/31/46
Due: 03/31/47
Phase: N/A
Priority: Normal
Start: 12/31/08
End: 09/30/10
Due: 09/30/11